SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
31 hedge funds and large institutions have $23.5M invested in scPharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
54% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 13
Holders
31
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.24M | |
| 2 | +$556K | |
| 3 | +$191K | |
| 4 |
Renaissance Technologies
New York
|
+$145K |
| 5 |
Millennium Management
New York
|
+$108K |
Top Sellers
| 1 | -$1.05M | |
| 2 | -$738K | |
| 3 | -$292K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$229K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$71.2K |